FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3201622860> ?p ?o ?g. }

• W3201622860 endingPage "1199" @default.
• W3201622860 startingPage "1192" @default.
• W3201622860 abstract "The properties and characteristics of different types of silk fibroin (SF) drug-loaded sustained-release carriers and their effects on the drug release behavior were reviewed, and the existing problems and development prospects of SF drug-loaded sustained-release carriers in tissue engineering drug delivery system were discussed.The literatures about drug-loaded SF sustained-release carriers in recent years were extensively consulted, and the types of sustained-release carriers, characteristics of drug release, range of applications, advantages and disadvantages, and solutions were summarized and analyzed.At present, the SF drug-loaded sustained-release carriers are mainly divided into SF microparticles, SF scaffolds, SF membranes, SF hydrogels, SF nanofibers, SF sponges, and so on. These types of SF drug-loaded sustained-release carriers have their own advantages and problems, of which the most prominent problem is the burst release of drugs at the initial stage. While, the initial burst release of drugs can be effectively solved by improving the preparation process and adjusting the material ratio. Different types of drug-loaded sustained-release carriers can be prepared by combining different materials to achieve different application scopes and drug release behaviors under different conditions.SF is a good drug-loaded carrier for tissue engineering, the burst release of drugs at the initial stage can be solved by improving the preparation process and changing the material structure; through the combination of the advantages of various types of SF drug-loaded sustained-release carriers, it is expected to prepare SF drug-loaded sustained-release carriers that meet different clinical needs.综述不同类型丝素蛋白（silk fibroin，SF）载药缓释载体的性能、特性以及对装载药物的释放行为影响，并对 SF 载药缓释载体目前在组织工程药物缓释系统中存在的问题与发展前景进行讨论。.广泛查阅近年关于 SF 载药缓释载体的文献，从缓释载体类型、药物释放特性、适用范围、存在的优点及不足、解决办法等方面进行总结分析。.目前制备的 SF 载药缓释载体主要分为 SF 微颗粒、SF 支架、SF 膜、SF 水凝胶、SF 纳米纤维、SF 海绵等；各类型 SF 载药缓释载体有各自优点及存在的问题，其中最突出问题是药物初期突释现象，通过改善制备工艺、调整材料配比参数等可有效解决药物初期突释。通过联合使用多种不同材料可制备出不同类型复合载药缓释载体，实现不同条件下的适用范围及不同的药物释放行为。.SF 是组织工程良好的药物载体，通过改进制备工艺、改变材料结构等方式可解决药物初期突释问题；通过对多种类型 SF 载药缓释载体优点进行结合，有望制备出符合不同临床需要的 SF 载药缓释载体。." @default.
• W3201622860 created "2021-09-27" @default.
• W3201622860 creator A5012292837 @default.
• W3201622860 creator A5064453339 @default.
• W3201622860 creator A5074555925 @default.
• W3201622860 creator A5075966684 @default.
• W3201622860 creator A5079984046 @default.
• W3201622860 date "2021-09-15" @default.
• W3201622860 modified "2023-09-25" @default.
• W3201622860 title "[Progress in the application of silk fibroin in tissue engineered drug delivery system]." @default.
• W3201622860 cites W2209235728 @default.
• W3201622860 cites W2226876203 @default.
• W3201622860 cites W2230500846 @default.
• W3201622860 cites W2295655559 @default.
• W3201622860 cites W2518118752 @default.
• W3201622860 cites W2530589003 @default.
• W3201622860 cites W2612445546 @default.
• W3201622860 cites W2756437510 @default.
• W3201622860 cites W2766214837 @default.
• W3201622860 cites W2775682658 @default.
• W3201622860 cites W2778353412 @default.
• W3201622860 cites W2784253629 @default.
• W3201622860 cites W2793567793 @default.
• W3201622860 cites W2810059531 @default.
• W3201622860 cites W2810375278 @default.
• W3201622860 cites W2895000912 @default.
• W3201622860 cites W2896155929 @default.
• W3201622860 cites W2904459033 @default.
• W3201622860 cites W2911952663 @default.
• W3201622860 cites W2913470561 @default.
• W3201622860 cites W2916483618 @default.
• W3201622860 cites W2922469710 @default.
• W3201622860 cites W2937323361 @default.
• W3201622860 cites W2938366757 @default.
• W3201622860 cites W2948814265 @default.
• W3201622860 cites W2952791736 @default.
• W3201622860 cites W2976086864 @default.
• W3201622860 cites W3006193284 @default.
• W3201622860 cites W3081694326 @default.
• W3201622860 cites W3087700436 @default.
• W3201622860 cites W3118041937 @default.
• W3201622860 cites W3133593320 @default.
• W3201622860 doi "https://doi.org/10.7507/1002-1892.202103066" @default.
• W3201622860 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8444144" @default.
• W3201622860 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34523288" @default.
• W3201622860 hasPublicationYear "2021" @default.
• W3201622860 type Work @default.
• W3201622860 sameAs 3201622860 @default.
• W3201622860 citedByCount "0" @default.
• W3201622860 crossrefType "journal-article" @default.
• W3201622860 hasAuthorship W3201622860A5012292837 @default.
• W3201622860 hasAuthorship W3201622860A5064453339 @default.
• W3201622860 hasAuthorship W3201622860A5074555925 @default.
• W3201622860 hasAuthorship W3201622860A5075966684 @default.
• W3201622860 hasAuthorship W3201622860A5079984046 @default.
• W3201622860 hasConcept C108586683 @default.
• W3201622860 hasConcept C122302759 @default.
• W3201622860 hasConcept C13245373 @default.
• W3201622860 hasConcept C136229726 @default.
• W3201622860 hasConcept C159985019 @default.
• W3201622860 hasConcept C163588942 @default.
• W3201622860 hasConcept C171250308 @default.
• W3201622860 hasConcept C185592680 @default.
• W3201622860 hasConcept C188027245 @default.
• W3201622860 hasConcept C192562407 @default.
• W3201622860 hasConcept C2779820397 @default.
• W3201622860 hasConcept C2780035454 @default.
• W3201622860 hasConcept C2780431358 @default.
• W3201622860 hasConcept C49892992 @default.
• W3201622860 hasConcept C71924100 @default.
• W3201622860 hasConcept C98274493 @default.
• W3201622860 hasConceptScore W3201622860C108586683 @default.
• W3201622860 hasConceptScore W3201622860C122302759 @default.
• W3201622860 hasConceptScore W3201622860C13245373 @default.
• W3201622860 hasConceptScore W3201622860C136229726 @default.
• W3201622860 hasConceptScore W3201622860C159985019 @default.
• W3201622860 hasConceptScore W3201622860C163588942 @default.
• W3201622860 hasConceptScore W3201622860C171250308 @default.
• W3201622860 hasConceptScore W3201622860C185592680 @default.
• W3201622860 hasConceptScore W3201622860C188027245 @default.
• W3201622860 hasConceptScore W3201622860C192562407 @default.
• W3201622860 hasConceptScore W3201622860C2779820397 @default.
• W3201622860 hasConceptScore W3201622860C2780035454 @default.
• W3201622860 hasConceptScore W3201622860C2780431358 @default.
• W3201622860 hasConceptScore W3201622860C49892992 @default.
• W3201622860 hasConceptScore W3201622860C71924100 @default.
• W3201622860 hasConceptScore W3201622860C98274493 @default.
• W3201622860 hasIssue "9" @default.
• W3201622860 hasLocation W32016228601 @default.
• W3201622860 hasOpenAccess W3201622860 @default.
• W3201622860 hasPrimaryLocation W32016228601 @default.
• W3201622860 hasRelatedWork W14373313 @default.
• W3201622860 hasRelatedWork W15390847 @default.
• W3201622860 hasRelatedWork W15715641 @default.
• W3201622860 hasRelatedWork W15905768 @default.
• W3201622860 hasRelatedWork W21320134 @default.
• W3201622860 hasRelatedWork W22504235 @default.
• W3201622860 hasRelatedWork W23167644 @default.

• next